Archived 4 years ago from The Burning PlatformThe FDA’s New Vaccine Strategy
Via Mercola [embedded content] Story at-a-glance When the bivalent COVID boosters against Omicron first came out, only those who had received the initial series of shots were eligible to receive them, but uptake was disappointing. Less than 5% of those eligible had taken a bivalent booster by …
Read More